BlackRock Group’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $963K | Buy |
28,737
+11,723
| +69% | +$393K | ﹤0.01% | 2138 |
|
|
2016
Q3 | $453K | Buy |
17,014
+4,976
| +41% | +$132K | ﹤0.01% | 2329 |
|
|
2016
Q2 | $265K | Buy |
12,038
+882
| +8% | +$19.4K | ﹤0.01% | 2462 |
|
|
2016
Q1 | $327K | Buy |
11,156
+819
| +8% | +$24K | ﹤0.01% | 2385 |
|
|
2015
Q4 | $341K | Sell |
10,337
-2,191
| -17% | -$72.3K | ﹤0.01% | 2341 |
|
|
2015
Q3 | $453K | Buy |
12,528
+848
| +7% | +$30.7K | ﹤0.01% | 2231 |
|
|
2015
Q2 | $525K | Buy |
11,680
+1,783
| +18% | +$80.1K | ﹤0.01% | 2237 |
|
|
2015
Q1 | $303K | Buy |
9,897
+1,767
| +22% | +$54.1K | ﹤0.01% | 2344 |
|
|
2014
Q4 | $413K | Sell |
8,130
-5,922
| -42% | -$301K | ﹤0.01% | 2293 |
|
|
2014
Q3 | $556K | Buy |
14,052
+9,011
| +179% | +$357K | ﹤0.01% | 2113 |
|
|
2014
Q2 | $217K | Buy |
5,041
+3,767
| +296% | +$162K | ﹤0.01% | 2414 |
|
|
2014
Q1 | $51K | Buy |
+1,274
| New | +$51K | ﹤0.01% | 2614 |
|
|
2013
Q4 | – | Sell |
-1,382
| Closed | -$32K | – | 2677 |
|
|
2013
Q3 | $32K | Buy |
+1,382
| New | +$32K | ﹤0.01% | 2754 |
|